###begin article-title 0
Decorin is a novel antagonistic ligand of the Met receptor
###end article-title 0
###begin p 1
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
Decorin, a member of the small leucine-rich proteoglycan gene family, impedes tumor cell growth by down-regulating the epidermal growth factor receptor. Decorin has a complex binding repertoire, thus, we predicted that decorin would modulate the bioactivity of other tyrosine kinase receptors. We discovered that decorin binds directly and with high affinity (Kd = approximately1.5 nM) to Met, the receptor for hepatocyte growth factor (HGF). Binding of decorin to Met is efficiently displaced by HGF and less efficiently by internalin B, a bacterial Met ligand. Interaction of decorin with Met induces transient receptor activation, recruitment of the E3 ubiquitin ligase c-Cbl, and rapid intracellular degradation of Met (half-life = approximately6 min). Decorin suppresses intracellular levels of beta-catenin, a known downstream Met effector, and inhibits Met-mediated cell migration and growth. Thus, by antagonistically targeting multiple tyrosine kinase receptors, decorin contributes to reduction in primary tumor growth and metastastic spreading.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 217 241 217 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Ramirez and Rifkin, 2003</xref>
###xml 243 268 243 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">Weigelt and Bissell, 2008</xref>
###xml 580 604 580 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">Schaefer and Iozzo, 2008</xref>
###xml 742 753 739 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Iozzo, 1998</xref>
###xml 798 817 795 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Iozzo et al., 1999b</xref>
###xml 890 913 887 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Goldoni and Iozzo, 2008</xref>
###xml 1052 1070 1049 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Grant et al., 2002</xref>
###xml 1129 1147 1126 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Petit et al., 1997</xref>
###xml 1264 1279 1261 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bi et al., 2008</xref>
###xml 1384 1403 1381 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Iozzo et al., 1999b</xref>
###xml 1290 1294 <span type="species:ncbi:10090">mice</span>
The extracellular matrix and its multiple constituents play both a structural and signaling role by interacting with surface receptors that ultimately affect gene expression, cell phenotypes, development, and cancer (Ramirez and Rifkin, 2003; Weigelt and Bissell, 2008). Decorin, a member of the small leucine-rich proteoglycan gene family that harbors one chondroitin/dermatan sulfate side chain at its N terminus, was originally named because of its ability to "decorate" collagen fibrils, thereby regulating fibrillogenesis, a key mechanism of matrix assembly and homeostasis (Schaefer and Iozzo, 2008). It was soon discovered that decorin regulates the TGF-beta signaling pathway and also inhibits the growth of a variety of tumor cells (Iozzo, 1998) by down-regulating the EGF receptor (EGFR; Iozzo et al., 1999b) and other members of the ErbB family of receptor tyrosine kinase (RTK; Goldoni and Iozzo, 2008). Decorin suppresses tumor cell-mediated angiogenesis by inhibiting the endogenous production of vascular endothelial cell growth factor (Grant et al., 2002) similar to neutralizing antibodies directed toward EGFR (Petit et al., 1997). Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation (Bi et al., 2008), whereas mice with a double deficiency of decorin and p53 succumb prematurely to aggressive lymphomas (Iozzo et al., 1999b). Together, these observations indicate that lack of decorin is permissive for in vivo tumorigenesis.
###end p 3
###begin p 4
###xml 182 201 182 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">Santra et al., 1995</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">2000</xref>
###xml 209 229 209 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Csord&#225;s et al., 2000</xref>
###xml 231 248 231 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Reed et al., 2002</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">2005</xref>
###xml 256 276 256 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib61">Tralh&#227;o et al., 2003</xref>
###xml 278 298 278 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Biglari et al., 2004</xref>
###xml 300 320 300 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">Seidler et al., 2006</xref>
###xml 440 460 440 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Csord&#225;s et al., 2000</xref>
###xml 473 492 473 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Santra et al., 2000</xref>
###xml 524 528 524 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAF1</sup>
###xml 618 637 618 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Santra et al., 2000</xref>
###xml 820 836 820 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">Zhu et al., 2005</xref>
###xml 896 916 896 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">Seidler et al., 2006</xref>
###xml 967 983 967 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Li et al., 2008b</xref>
###xml 1070 1090 1070 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Goldoni et al., 2008</xref>
###xml 1092 1113 1092 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">Shintani et al., 2008</xref>
###xml 1236 1261 1236 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib64">Zafiropoulos et al., 2008</xref>
Ectopic expression of decorin induced by stable transgenic systems, viral vectors, or inducible promoters attenuates the growth of tumor xenografts with diverse histogenetic origin (Santra et al., 1995, 2000; Csordas et al., 2000; Reed et al., 2002, 2005; Tralhao et al., 2003; Biglari et al., 2004; Seidler et al., 2006). Decorin slows the growth of squamous cell and breast carcinomas by inducing a sustained down-regulation of the EGFR (Csordas et al., 2000) and ErbB2 (Santra et al., 2000), a process that leads to a p21WAF1-mediated growth suppression and enhanced cytodifferentiation of mammary carcinoma cells (Santra et al., 2000). The basic mechanism has been partially elucidated and includes direct binding to the EGFR followed by protracted internalization of the receptor via caveolar-mediated endocytosis (Zhu et al., 2005) and the triggering of apoptosis via caspase-3 activation (Seidler et al., 2006). Moreover, decorin inhibits myeloma cell growth (Li et al., 2008b), and systemic delivery of decorin reduces pulmonary metastases in two animal models (Goldoni et al., 2008; Shintani et al., 2008). Notably, decorin-induced growth inhibition in osteosarcoma MG63 cells is overcome by a constitutive activation of EGFR (Zafiropoulos et al., 2008).
###end p 4
###begin p 5
###xml 80 100 80 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Brandan et al., 2008</xref>
###xml 102 126 102 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">Schaefer and Iozzo, 2008</xref>
###xml 168 185 168 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Reed et al., 2002</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">2005</xref>
###xml 193 213 193 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Goldoni et al., 2008</xref>
###xml 489 525 489 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Danilkovitch-Miagkova and Zbar, 2002</xref>
###xml 527 550 527 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Birchmeier et al., 2003</xref>
###xml 552 581 552 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Knudsen and Vande Woude, 2008</xref>
Because of the complex binding capabilities of decorin toward multiple targets (Brandan et al., 2008; Schaefer and Iozzo, 2008) and its dramatic antioncogenic effects (Reed et al., 2002, 2005; Goldoni et al., 2008), we predicted a role for decorin in modulating the bioactivity of other RTK. We discovered that decorin binds directly to the Met receptor, also known as hepatocyte growth factor (HGF) receptor, an established mediator of malignant transformation, invasion, and metastasis (Danilkovitch-Miagkova and Zbar, 2002; Birchmeier et al., 2003; Knudsen and Vande Woude, 2008). Our findings indicate that decorin is a novel antagonistic ligand of the Met receptor. Apart from HGF, decorin is the only mammalian ligand known to date. Interaction between decorin and the extracellular domain of Met leads to receptor down-regulation through a combination of enhanced ectodomain shedding and internalization. Decorin-induced inhibition of Met activity results in suppression of key biological events. Notably, decorin induces a marked proteasome-dependent degradation of the transcription factor beta-catenin and inhibits Met-dependent cell motility. Collectively, our findings point to decorin as a novel inhibitor of the Met receptor. The ability of decorin to antagonize multiple receptors, including Met, EGFR, and ErbB2/ErbB4, suggests that this leucine-rich proteoglycan might have therapeutic value in treatment of cancers in which several RTKs are coactivated.
###end p 5
###begin title 6
Results
###end title 6
###begin title 7
Decorin down-regulates the Met receptor
###end title 7
###begin p 8
###xml 311 319 311 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 365 384 365 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Iozzo et al., 1999b</xref>
###xml 535 543 535 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 614 622 614 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 804 823 804 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Santra et al., 2000</xref>
###xml 825 841 825 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">Zhu et al., 2005</xref>
To discover new pathways affected by decorin, we used an antibody array system that simultaneously examines the relative Tyr phosphorylation level of 42 different RTKs. After a 15-min exposure of quiescent (serum starved) HeLa cells to 100 nM recombinant decorin, there was a rapid phosphorylation of the EGFR (Fig. 1 A) in agreement with our previous experiments (Iozzo et al., 1999b). In addition, a novel target was found in the Met receptor, which showed a decorin-evoked increase in phosphorylation when the cells were quiescent (Fig. 1 A) and a marked suppression when the cells were cultured in full serum (Fig. 1 B). Note that under the latter conditions, Tyr phosphorylation of EGFR, ErbB2, and ErbB4 receptors was markedly down-regulated by decorin in full agreement with our previous studies (Santra et al., 2000; Zhu et al., 2005), thereby validating our approach.
###end p 8
###begin p 9
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Decorin affects Met receptor signaling and turnover.</bold>
Decorin affects Met receptor signaling and turnover. (A) Phospho-RTK arrays. HeLa cells were treated with decorin for 15 min. RTK membranes were incubated with cell lysates. The duplicate dots at each corner represent phospho-Tyr positive controls. (B) The same experiment as in A using nonquiescent cells. (C, top) Representative immunoblot of a short decorin time course showing phosphorylation of the Met receptor at Tyr1234/5, total Met, and beta-actin. (bottom) Quantification of immunoblots similar to those shown in the top from three independent experiments performed in triplicate. Values represent the mean +/- SEM (**, P < 0.01). (D) Best-fit plot of Met receptor degradation over time. Relative values were obtained by scanning densitometry (chemiluminescence) of blots as in C and represent means +/- SEM from three independent experiments performed in triplicate.
###end p 9
###begin p 10
###xml 349 357 349 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 499 507 487 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 629 637 617 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 820 840 808 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Berthou et al., 2004</xref>
###xml 935 936 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 936 939 924 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 963 971 939 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 1281 1301 1233 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Hammond et al., 2003</xref>
###xml 1527 1547 1479 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Hammond et al., 2003</xref>
Next, we performed dose-response and time course experiments to investigate the effects of decorin on Met phosphorylation kinetics. We used a phosphoantibody specific for the two Tyr residues located within the Met catalytic domain, Tyr1234 and Tyr1235. Decorin treatment of serum-starved cells evoked a transient phosphorylation of these residues (Fig. 1 C, top). In several experiments, we found a significant peak in phosphorylation at approximately10 min followed by pronounced down-regulation (Fig. 1 C, bottom). Interestingly, decorin induced a marked decrease in steady-state levels of Met, as detected by immunoblotting (Fig. 1 C, top). It is important to note that Met kinase activity was required for decorin-evoked down-regulation of Met, as tested by using SU11274, a specific Met tyrosine kinase inhibitor (Berthou et al., 2004; unpublished data). Remarkably, the levels of total Met receptor declined very rapidly with a t1/2 of approximately6 min (Fig. 1 D) and partially recovered at approximately60 min after treatment. However, even after 24 h of continuous decorin treatment, the Met levels were only approximately50% of control values (unpublished data). The kinetics of decorin-evoked Met phosphorylation were similar to those published for HGF in HeLa cells (Hammond et al., 2003), with a peak between 5 and 10 min of stimulation. In contrast, the kinetics of total Met degradation induced by HGF were much slower than those of decorin, showing a comparable down-regulation only after a 60-min treatment (Hammond et al., 2003), although those experiments were performed in full serum. These data suggest a role for decorin as a partial agonist insofar as it activates the Met kinase domain but with an outcome different from that evoked by HGF.
###end p 10
###begin title 11
Decorin binds directly to the Met receptor: functional and biochemical evidence
###end title 11
###begin p 12
###xml 109 128 109 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Iozzo et al., 1999b</xref>
###xml 348 363 348 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Jo et al., 2000</xref>
###xml 365 388 365 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Birchmeier et al., 2003</xref>
###xml 390 406 390 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Li et al., 2008a</xref>
###xml 408 427 408 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Reznik et al., 2008</xref>
###xml 628 647 628 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Rodeck et al., 1987</xref>
###xml 703 727 703 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Levitzki and Gazit, 1995</xref>
###xml 881 889 881 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 1076 1084 1076 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
We have previously shown that decorin binds directly to the EGFR, initiating a cohort of cellular responses (Iozzo et al., 1999b). Receptor cross talk is prevalent in cancer progression, and Met and EGFR are no exception, with many studies showing a link between the two either through direct interaction or by convergence of downstream signaling (Jo et al., 2000; Birchmeier et al., 2003; Li et al., 2008a; Reznik et al., 2008). To assess whether the observed effects on Met could be indirectly attributed to decorin/EGFR binding, we used two different EGFR-blocking strategies: either the blocking monoclonal antibody mAb425 (Rodeck et al., 1987) or AG1478, a specific EGFR tyrosine kinase inhibitor (Levitzki and Gazit, 1995). Preincubation for 1 h with mAb425 was sufficient to abrogate EGFR activation as demonstrated by a complete lack of phosphorylation in response to EGF (Fig. 2 A). Blocking EGFR kinase activity with AG1478 gave similar results (unpublished data). Even in the absence of EGFR activity, decorin evoked a rapid activation of the Met catalytic domain (Fig. 2 B) with no change in overall kinetics and a concurrent down-regulation of total Met. We conclude that Met receptor activation by decorin is independent of the EGFR.
###end p 12
###begin p 13
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Decorin interacts with the Met receptor.</bold>
###xml 892 893 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 893 894 874 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
Decorin interacts with the Met receptor. (A) 1 microg/ml mAb425, an EGFR-specific blocking antibody, was tested before experiments in combination with decorin by evaluating its effect in inhibiting EGF-dependent (16 nM) EGFR phosphorylation. (B, top) Immunoblot of a short decorin (100 nM) time course showing phosphorylation of the Met receptor at Tyr1234/5, total Met, and beta-actin in the presence or absence of 1 microg/ml mAb425. (bottom) Quantification of immunoblots similar to those shown in the top panel. Values represent the mean +/- SEM from three independent experiments performed in triplicate (*, P < 0.05; **, P < 0.01). (C) Immunoblots detecting Met (left) and decorin (right) in cells treated with decorin protein core for 15 min, cross-linked with 500 nM S-SMPB for 20 min at 37degreesC, and immunoprecipitated with an anti-C terminus Met antibody. Arrows point to a high Mr complex of Met and decorin protein core (approximately190 kD). The asterisk indicates Met monomer (approximately140 kD). (D) Silver-stained gel. Notice that the entire Met-Fc is bound to the protein A-Sepharose beads. Smear is the carrier proteins. (E) Immunoblotting (IB) of HGF after pull-down with protein A beads-Met-Fc. (F) Immunoblotting of decorin after pull-down with either protein A beads-Met-Fc or beads alone. Note the absence of HGF or decorin in the supernatants, indicating that essentially all of the ligands were bound. IP, immunoprecipitation. (D-F) Values shown are given in kiloDaltons.
###end p 13
###begin p 14
###xml 540 548 528 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 719 727 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
This observation led us to hypothesize that decorin may act through a direct interaction with the Met receptor. To explore this possibility, we used a noncleavable impermeable cross-linker, S-SMPB (sulfo-succinimidyl-4-(p-maleimidophenyl)-butyrate). After cross-linking, the Met receptor was immunoprecipitated with an antibody specific for the intracellular C-terminal domain, and immunoblotting was performed to detect Met and decorin. We found that decorin protein core coimmunoprecipitated with Met in a complex of approximately190 kD (Fig. 2 C, arrows). The size of the complex suggests a 1:1 stoichiometry between decorin protein core (approximately50 kD) and the beta chain of the receptor (approximately140 kD; Fig. 2 C, asterisk).
###end p 14
###begin p 15
###xml 259 267 259 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 336 344 336 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
###xml 372 380 372 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 F</xref>
###xml 248 253 <span type="species:ncbi:9606">human</span>
Next, the physical interaction of decorin with Met was established in pull-down experiments using protein A-linked Sepharose beads, which efficiently bound a Met-Fc chimera comprised of the extracellular domain of the Met fused to the Fc region of human IgG (Fig. 2 D). By this approach, we were able to efficiently pull down both HGF (Fig. 2 E) and decorin protein core (Fig. 2 F). Some decorin bound nonspecifically to the beads, but the presence of Met-Fc led to a significant enrichment in decorin binding.
###end p 15
###begin p 16
###xml 185 200 185 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, A and B</xref>
###xml 208 209 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 454 455 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 494 509 494 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, C and D</xref>
###xml 571 572 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 903 914 901 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Iozzo, 2005</xref>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
Next, we determined the binding affinity of decorin to immobilized Met-Fc chimera using solid-phase assays. Both decorin and decorin protein core bound to Met-Fc in a saturable manner (Fig. 3, A and B) with Kd of 2.2 nM and 1.5 nM, respectively. The biological activity of decorin and decorin protein core was tested by using fibrillar collagen type I, a known ligand for decorin. In this case, decorin and decorin core bound in a saturable manner with Kd of 0.25 nM and 0.28 nM, respectively (Fig. 3, C and D). In our assay, the binding of HGF alone to Met-Fc showed a Kd of 0.95 nM +/- 0.47 (). As a negative control, we used a mouse monoclonal antibody as immobilized substrate, and no significant binding to decorin was observed (Fig. S1 B), ruling out the possibility that decorin binds nonspecifically to the Fc portion of the Met-Fc chimera. In addition, LG3 (the C-terminal portion of perlecan; Iozzo, 2005) did not interact with Met-Fc (Fig. S1 C). This rules out a role for the His tag in the binding insofar as LG3 has a His tag as decorin, it is a protein of similar size to decorin, and is expressed in the same eukaryotic cell system (293-EBNA cells).
###end p 16
###begin p 17
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Affinity interaction between decorin and the Met receptor.</bold>
###xml 508 510 496 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 578 580 554 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
Affinity interaction between decorin and the Met receptor. (A-E) Ligand-binding assays using decorin, decorin protein core, or internalin B as soluble ligands and Met-Fc or fibrillar collagen I as immobilized substrates. (F) Competition experiments using constant amounts of decorin core (10 nM) and increasing amounts of internalin B or HGF as indicated. Notice that only at high molar ratios (20:1 and 40:1), internalin B significantly (approximately70%) reduces decorin protein core binding to the Met (IC50 = approximately180 nM). In contrast, HGF is much more efficient (IC50 = approximately2.5 nM) in displacing decorin core. Values represent the mean +/- SEM.
###end p 17
###begin p 18
###xml 231 254 231 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Birchmeier et al., 2003</xref>
###xml 338 360 338 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 378 395 378 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">Shen et al., 2000</xref>
###xml 397 409 397 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Ireton, 2007</xref>
###xml 411 430 411 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Disson et al., 2008</xref>
###xml 530 550 530 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Niemann et al., 2007</xref>
###xml 552 572 552 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Niemann et al., 2008</xref>
###xml 644 665 644 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Basilico et al., 2008</xref>
###xml 717 736 717 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">Stamos et al., 2004</xref>
###xml 966 967 966 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 990 998 990 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 E</xref>
###xml 1016 1017 1016 1017 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1079 1099 1079 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Machner et al., 2003</xref>
###xml 1409 1411 1409 1411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1490 1498 1478 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 F</xref>
###xml 1572 1574 1548 1550 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1608 1616 1572 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 F</xref>
###xml 338 360 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Two ligands of Met have been previously identified: the mammalian HGF and a bacterial leucine-rich repeat surface protein called internalin B. HGF plays key roles in promoting epithelial cell motility, growth, and differentiation (Birchmeier et al., 2003). Internalin B activates Met, leading to internalization of the bacterial pathogen Listeria monocytogenes into host cells (Shen et al., 2000; Ireton, 2007; Disson et al., 2008). Recent structural studies have shown that internalin B binds to the first Ig-like domain of Met (Niemann et al., 2007; Niemann et al., 2008). In contrast, HGF binds with high affinity to the Met terminal Ig3-4 (Basilico et al., 2008) and with lower affinity to the semaphorin domain (Stamos et al., 2004). To determine whether decorin binds to regions within the Met ectodomain that overlap with those used by HGF or internalin B, we performed competitive binding assays. First, we found that internalin B bound with high affinity (Kd = 2.16 nM) to Met-Fc (Fig. 3 E). Note that the Kd for Met/internalin B was previously reported to be 20-30 nM (Machner et al., 2003). A possible explanation for this discrepancy in the observed affinity could be that the Met-Fc used in our study is a dimer and fully glycosylated, whereas the Met used in the referenced study was a monomer and produced in glycosylation-deficient cells. HGF very effectively (50% inhibitory concentration [IC50] = approximately2.3 nM) competed with decorin protein core binding to Met-Fc (Fig. 3 F). In comparison, internalin B was approximately52-fold less efficient (IC50 = approximately120 nM) than HGF (Fig. 3 F). Because the overall affinity constants for decorin, internalin B, and HGF are relatively close (0.95-2.16 nM) in our assays, the conclusions from the competition experiments can be assessed as differential binding sites on the Met ectodomain for these ligands.
###end p 18
###begin p 19
Collectively, our results demonstrate that decorin is a high affinity ligand of the Met receptor insofar as it shows saturable kinetics of binding and displacement by two established Met ligands. Moreover, the more efficient displacement by HGF suggests that decorin and HGF bind to overlapping sites on the Met ectodomain and further suggests that the decorin's antagonistic effects might be the result of a unique mode of binding within the Met receptor.
###end p 19
###begin title 20
Decorin evokes differential tyrosine phosphorylation of the Met receptor
###end title 20
###begin p 21
###xml 76 84 76 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 89 97 89 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 294 302 294 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 304 327 304 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Birchmeier et al., 2003</xref>
###xml 555 578 555 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Birchmeier et al., 2003</xref>
###xml 815 836 815 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Petrelli et al., 2002</xref>
In response to decorin binding, the kinase domain of Met is phosphorylated (Fig. 1 C and Fig. 2 B). In addition to Tyr1234/5, several other Tyr residues in the cytoplasmic tail of the Met receptor are known to undergo agonist-induced phosphorylation and play key roles in downstream signaling (Fig. 4 A; Birchmeier et al., 2003). For example, phosphorylation of Tyr1349 and Tyr1356 recruit the adaptor proteins Gab1 and Grb2, respectively, which are responsible for mediating most of the complex cellular responses (motility, growth, and differentiation; Birchmeier et al., 2003). Conversely, phosphorylation of Tyr1003 is involved in negative regulation of the receptor via recruitment of the E3 ubiquitin ligase c-Cbl, which is responsible for Met polyubiquitination and subsequent degradation in the proteasome (Petrelli et al., 2002).
###end p 21
###begin p 22
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Decorin induces differential and selective phosphorylation of Met Tyr residues.</bold>
Decorin induces differential and selective phosphorylation of Met Tyr residues. (A) Diagram of the main Met receptor Tyr phosphorylation sites and adaptor proteins. CAS, Crk-associated substrate; P, phosphate. (B, top) Representative immunoblots of a short decorin (100 nM) time course showing phosphorylation of the Met receptor at Tyr1003 and total Met amount vis a vis 1.5 nM HGF. (bottom) Quantification of immunoblots from three independent experiments. (C) Coimmunoprecipitation of c-Cbl and Met using an antibody directed toward the intracellular domain of Met. 100 nM decorin treatment was performed for 10 min. (D, top) Representative immunoblot showing phosphorylation of the Met receptor at Tyr1349 and total Met after 100 nM decorin treatment vis a vis 1.5 nM HGF. (bottom) Quantification of immunoblots from three independent experiments performed in triplicate. (E) Recruitment of Grb2 to the Met receptor mediated by 100 nM decorin. Coimmunoprecipitation of the Met receptor and Grb2 using an anti-Met C terminus antibody for the immunoprecipitation (IP) and either the same antibody or an anti-Grb2 monoclonal antibody for the immunoblotting (IB). Values represent the mean +/- SEM (*, P < 0.05; **, P < 0.01; ***, P < 0.001). All of the relative values were obtained by scanning densitometry (chemiluminescence). (B-E) Values shown are given in kiloDaltons.
###end p 22
###begin p 23
###xml 45 53 45 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 133 141 133 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 200 208 200 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 213 221 213 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 432 440 432 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
Decorin promoted phosphorylation of Tyr1003 (Fig. 4 B, top), which was slightly delayed in comparison to HGF, with a peak at 15 min (Fig. 4 B, bottom). Like the phosphorylation of residues 1234/1235 (Fig. 1 C and Fig. 2 B), phosphorylation of Tyr1003 in response to decorin was transient, with levels diminishing thereafter (not depicted). In support of this result, c-Cbl was recruited to the Met receptor after decorin treatment (Fig. 4 C).
###end p 23
###begin p 24
###xml 126 134 126 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 281 289 281 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 294 302 294 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 379 387 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
###xml 682 697 682 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Li et al., 2007</xref>
Interestingly, the C-terminal Tyr1349 failed to be activated in response to decorin, whereas cells robustly responded to HGF (Fig. 4 D). This finding was unexpected, given that decorin induces efficient activation of Met, as assessed by phosphorylation of the catalytic Tyr1234/5 (Fig. 1 C and Fig. 2 B). Moreover, decorin induced robust recruitment of Grb2 to the Met receptor (Fig. 4 E). Because phosphorylated Tyr1356 serves as docking site for Grb2, this finding strongly suggests that decorin induces efficient phosphorylation of this Tyr residue. Notably, Tyr1356 is essential for receptor internalization, and Grb2 also indirectly recruits c-Cbl, leading to Met degradation (Li et al., 2007). Unfortunately, we were unable to directly assess phosphorylation of Tyr1356 because of the fact that phospho-specific antibodies recognizing this residue are not commercially available.
###end p 24
###begin p 25
###xml 503 518 503 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, B and D</xref>
###xml 563 571 563 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
Collectively, our results show that decorin differentially affects key Tyr residues involved in Met signaling and homeostasis, inducing efficient phosphorylation of Tyr1356 and Tyr1003 while inhibiting phosphorylation of Tyr1349, the sole Tyr associated with downstream signaling events. Decorin and HGF activate the receptor in subtly different ways, perhaps by inducing different receptor conformations. This ability may be responsible for the more efficient down-regulation of Met caused by decorin (Fig. 4, B and D, top) and the lack of downstream signaling (Fig. 4 D, bottom).
###end p 25
###begin title 26
Decorin causes Met down-regulation by inducing both ectodomain shedding and internalization
###end title 26
###begin p 27
###xml 159 176 159 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Nath et al., 2001</xref>
###xml 178 198 178 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Athauda et al., 2006</xref>
###xml 200 221 200 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Petrelli et al., 2006</xref>
###xml 301 322 301 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Petrelli et al., 2006</xref>
It is known that Met can be down-regulated not only via Cbl-mediated ubiquitination and degradation in the proteasome, but also by shedding of its ectodomain (Nath et al., 2001; Athauda et al., 2006; Petrelli et al., 2006). Specifically, the shedding is induced by a monoclonal Met-blocking antibody (Petrelli et al., 2006), which is effective in inhibiting primary tumor growth and metastastic spreading. Thus, we tested whether decorin could use a similar mechanism of action. Media conditioned by cells treated with decorin contained higher levels of shed Met ectodomain than controls ().
###end p 27
###begin p 28
###xml 176 193 176 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Nath et al., 2001</xref>
It has been reported that the Met ectodomain can be released from the plasma membrane through activation of the EGFR, a process that is mediated by a TIMP-3-sensitive pathway (Nath et al., 2001). Accordingly, we tested TIMP-2 and TIMP-3 ability to prevent decorin-dependent Met down-regulation. Both matrix metalloproteinase inhibitors were effective in blocking decorin activity on the Met receptor (Fig. S2 B, top). We observed that the full-length Met levels in cells incubated with the inhibitors were slightly higher than in control cells (Fig. S2 B, bottom). This suggests the existence of a basal level of receptor shedding, which is inhibited by TIMP-2 and TIMP-3. To test this possibility, we determined the amount of Met receptor shed into the media conditioned by cells treated with decorin in the presence or absence of the inhibitors. The results showed that both TIMP-2 and TIMP-3 reduced the amount of Met shedding (Fig. S2 C). Note that the control medium (Fig. S2 C) was conditioned for 24 h, showing a significant level of basal Met shedding (compare with Fig. S2 A).
###end p 28
###begin p 29
To verify the contribution of Met internalization to Met down-regulation upon decorin binding, HeLa cells were treated for 5 and 30 min, subjected to immunostaining with a Met N terminus antibody, and analyzed by fluorescence microscopy (Fig. S2 D). Over time, decorin induced receptor relocation from the plasma membrane to intracellular compartments and perinuclear regions. This evidence was corroborated by biochemical data showing the presence of Met upon decorin treatment followed by trypsin digestion (Fig. S2 E). This assay is based on the fact that only internalized Met is not accessible to digestion. Collectively, our results provide a novel mechanism of action for decorin: inhibition of the Met receptor biological activity via a dual activity comprising enhanced shedding and intracellular degradation.
###end p 29
###begin title 30
Decorin down-regulates beta-catenin and induces apoptosis via the Met receptor
###end title 30
###begin p 31
###xml 140 158 137 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Monga et al., 2002</xref>
###xml 160 179 157 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Herynk et al., 2003</xref>
###xml 181 200 178 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Rasola et al., 2007</xref>
###xml 332 340 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 436 455 403 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Aberle et al., 1997</xref>
###xml 536 544 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
Next, we investigated whether decorin-evoked Met down-regulation could impair the beta-catenin pathway, a known downstream effector of Met (Monga et al., 2002; Herynk et al., 2003; Rasola et al., 2007). After decorin treatment, beta-catenin levels declined by approximately70% and approximately90% after 6 h and 24 h, respectively (Fig. 5 A). This degradation occurred via the proteasome, the main degradation pathway for beta-catenin (Aberle et al., 1997), insofar as it was completely blocked by the proteasome inhibitor lactacystin (Fig. 5 B).
###end p 31
###begin p 32
###xml 0 57 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Decorin down-regulates &#946;-catenin via the Met receptor.</bold>
Decorin down-regulates beta-catenin via the Met receptor. (A, top) Representative immunoblots of HeLa cells treated with 100 nM decorin for the times indicated and probed for beta-catenin. Tubulin was used as a loading control. (bottom) Quantification of immunoblots as those presented in the top panel from three independent experiments. (B, top) beta-Catenin levels after treatment with 100 nM decorin for 30 min in the presence or absence of 10 microM of the proteasome inhibitor lactacystin. Cells were preincubated with lactacystin for 1 h before adding decorin. (bottom) Quantification of immunoblots as those presented in the top panel from three independent experiments. (C, top) beta-Catenin and PARP immunoblots after treatment with 100 nM decorin for 6 h in the presence or absence of the tyrosine kinase inhibitors AG1478 and SU11274 (both 1 microM) as indicated. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as loading control. (bottom) Quantification of immunoblots as those presented in the top panel from three independent experiments performed in triplicate. Values represent the mean +/- SEM (*, P < 0.05; **, P < 0.01). All of the relative values were obtained by scanning densitometry (chemiluminescence). Values shown in blots are given in kiloDaltons.
###end p 32
###begin p 33
###xml 107 131 107 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Levitzki and Gazit, 1995</xref>
###xml 133 153 133 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Berthou et al., 2004</xref>
###xml 350 358 344 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 565 573 556 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 766 785 754 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, A, C, and E</xref>
###xml 887 902 872 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, B and D</xref>
###xml 1044 1066 1023 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Klein and Melton, 1996</xref>
###xml 1251 1259 1224 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 F</xref>
###xml 1690 1698 1654 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 G</xref>
Next, we preincubated the cells with AG1478 and SU11274, EGFR and Met-specific tyrosine kinase inhibitors (Levitzki and Gazit, 1995; Berthou et al., 2004), respectively, in the presence or absence of decorin. AG1478 was not capable of inhibiting decorin effect on beta-catenin levels, whereas SU11274 blocked decorin-evoked beta-catenin degradation (Fig. 5 C). Importantly, the effect of decorin on the beta-catenin pathway was direct and not the result of induction of apoptosis as proven by lack of poly ADP-ribose polymerase (PARP) cleavage after 6-h treatment (Fig. 5 C, top). In agreement with the biochemical data, the total levels of beta-catenin were markedly reduced by decorin treatment as detected by qualitative and quantitative fluorescence microscopy (Fig. 6, A, C, and E). Notably, there was a marked displacement of beta-catenin from perinuclear to plasmalemmal regions (Fig. 6, B and D). Finally, we tested whether decorin could cause beta-catenin degradation in the presence or absence of LiCl, a known inhibitor of GSK3beta (Klein and Melton, 1996). The results clearly showed that LiCl potently stabilized beta-catenin levels in the absence of decorin but was not capable of inhibiting decorin-evoked beta-catenin down-regulation (Fig. 6 F). These findings were corroborated by functional tests assessing beta-catenin transcriptional activity. We performed transient cell transfection assays using the TopFlash reporter vector, which drives the expression of a luciferase reporter gene under the control of a T cell factor promoter, which is activated by endogenous beta-catenin. Decorin significantly inhibited beta-catenin activity in the presence or absence of LiCl (Fig. 6 G). The persistence of decorin activity in the presence of LiCl suggests that decorin evokes down-regulation of beta-catenin independently of the canonical Wnt pathway, which requires GSK3beta.
###end p 33
###begin p 34
###xml 0 68 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Decorin attenuates &#946;-catenin levels and transcriptional activity.</bold>
###xml 1172 1185 1126 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R. reniformis</italic>
###xml 1408 1421 1362 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R. reniformis</italic>
###xml 1172 1185 <span type="species:ncbi:6136">R. reniformis</span>
###xml 1408 1421 <span type="species:ncbi:6136">R. reniformis</span>
Decorin attenuates beta-catenin levels and transcriptional activity. (A-D) Representative beta-catenin immunofluorescence images of HeLa cells after a 2-h incubation with or without 100 nM decorin. Notice the marked decline in beta-catenin levels throughout the cytoplasm and perinuclear regions in the decorin-treated cells. In contrast, the plasma membrane localization of beta-catenin increases (D, arrows). Nu, nucleus. Bars: (A and C) 50 microm; (B and D) 10 microm. (E) Quantification of the fluorescence intensity of images similar to those shown in A and C. The values represent the mean +/- SEM of 12 images (approximately120 cells/image) from four independent experiments. (F) Decorin inhibits beta-catenin activity via a GSK3-beta-independent mechanism. Representative beta-catenin immunoblot of HeLa lysates treated with 100 nM decorin for 6 h in the presence or absence of 30 mM of the GSK3-beta inhibitor LiCl. Cells were preincubated with LiCl for 1 h in full serum before decorin treatment. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. (G) HeLa cells were cotransfected with the TopFlash vector and a vector carrying the R. reniformis luciferase. 12 h after transfection, cells were treated with or without 100 nM decorin or LiCl for 6 h. Luciferase activity was measured after incubation with the cognate substrate luciferin. The values were normalized on R. reniformis luciferase activity. Cells preincubated with 30 mM LiCl, as in F, showed the same degree of reduction in luciferase activity when treated with decorin. Notice that LiCl enhances beta-catenin activity (***, P < 0.001). The values represent the mean +/- SEM of five independent experiments performed in triplicate. TCF, T cell factor.
###end p 34
###begin p 35
###xml 91 111 91 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">Seidler et al., 2006</xref>
###xml 124 144 124 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Goldoni et al., 2008</xref>
Next, on the basis of our previous studies showing that decorin induces apoptosis of A431 (Seidler et al., 2006) and MTLn3 (Goldoni et al., 2008) cells, we tested whether the same would happen in HeLa cells and whether the Met receptor could be linked to decorin-evoked apoptosis. Decorin treatment stimulated significant PARP cleavage after 24 h, and this effect was blocked by SU11274 (). Moreover, decorin induced caspase-3/7 activity comparable with the levels induced by etoposide, an inhibitor of the topoisomerase II enzyme, and it did so in a Met-dependent manner (Fig. S3 B). VAD, a pancaspase inhibitor, was used to block decorin's activity, and its effects can be compared to those evoked by the Met kinase inhibitor SU11274. These results suggest that Met phosphorylation is required for decorin-evoked apoptosis and reinforce our evidence that the Met receptor is a key player in decorin's mechanism of action.
###end p 35
###begin title 36
Decorin inhibits cell motility by a mechanism that involves both Met and EGFR
###end title 36
###begin p 37
###xml 90 113 90 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Birchmeier et al., 2003</xref>
###xml 225 245 225 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Goldoni et al., 2008</xref>
Deregulation of the Met receptor has been linked to the invasive behavior of tumor cells (Birchmeier et al., 2003). We have recently shown that decorin can prevent metastastic spreading to the lungs in a breast cancer model (Goldoni et al., 2008). In this study, we add an in vitro functional assay to support the relevance of our findings. HeLa cells were grown to confluency, "scratched" to allow motility, and treated with decorin for 24 h in the presence or absence of AG1478, H9786, a Met-blocking antibody, or the combination of both. Decorin significantly inhibited cell migration compared with control cells (). Both AG1478 and H9786, used alone, were effective but to a lesser extent than decorin. Interestingly, when decorin was used in combination with either inhibitor, it prevented wound closure even further than the individual compounds. When decorin was added in the presence of both inhibitors, it did not have any additional effect (Fig. S4, bottom). These data support the idea that both Met and EGFR are important to sustain cell migration and that decorin inhibits in vitro cell motility by a dual action on both receptors. Note that decorin is capable of down-regulating the Met receptor also in full-serum medium (Fig. S3 C), supporting the biological data regarding inhibition of the beta-catenin pathway and cell migration, both performed in the presence of serum. In addition, once decorin is removed from the cells, Met expression is recovered over time, indicating that the cells are healthy and apoptosis is not occurring.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 440 468 440 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib62">Trusolino and Comoglio, 2002</xref>
###xml 470 493 470 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Birchmeier et al., 2003</xref>
###xml 776 796 776 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Gentile et al., 2008</xref>
The multifaceted ability of decorin to retard in vivo tumor growth and metastatic spreading has a mechanistic explanation in decorin's ability to down-regulate multiple signaling pathways. We show for the first time that decorin is a novel endogenous antagonistic ligand of the Met receptor. Signaling mediated by HGF/Met axis promotes multiple biological activities, including survival, proliferation, motility/invasion, and angiogenesis (Trusolino and Comoglio, 2002; Birchmeier et al., 2003). Deregulation of the Met signaling pathway leads to uncontrolled growth and transformation, as shown by the TPR-Met, an oncogene that exhibits constitutive tyrosine kinase activation, and by activating mutations of Met intracellular domain in both hereditary and sporadic cancers (Gentile et al., 2008). Our results indicate that decorin is an inhibitor of multiple RTKs, insofar as it down-regulates the Met receptor as well as ErbB family members. The unique activity of decorin as a Met antagonist is manifested by a rapid induction of both Met receptor shedding and internalization with consequent downstream degradation of beta-catenin, which is required for cell survival.
###end p 39
###begin p 40
###xml 167 189 167 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lysteria monocytogenes</italic>
###xml 327 342 327 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Li et al., 2005</xref>
###xml 397 414 397 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">Shen et al., 2000</xref>
###xml 471 488 471 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">Shen et al., 2000</xref>
###xml 490 502 490 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Ireton, 2007</xref>
###xml 504 523 504 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Disson et al., 2008</xref>
###xml 635 653 635 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Braun et al., 1999</xref>
###xml 821 841 821 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Niemann et al., 2007</xref>
###xml 843 863 843 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Niemann et al., 2008</xref>
###xml 1019 1038 1019 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">Stamos et al., 2004</xref>
###xml 1213 1233 1213 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Niemann et al., 2008</xref>
###xml 1384 1404 1384 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Machner et al., 2003</xref>
###xml 1488 1508 1488 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Niemann et al., 2007</xref>
###xml 1588 1608 1588 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Machner et al., 2003</xref>
###xml 167 189 <span type="species:ncbi:1639">Lysteria monocytogenes</span>
To date, there is only one known mammalian ligand of the Met receptor (i.e., HGF) and one bacterial protein, internalin B, which is synthesized and partly secreted by Lysteria monocytogenes. Internalin B, a protein containing seven leucine-rich tandem repeats with homology to decorin, mimics HGF-induced receptor trafficking (Li et al., 2005) and causes sustained activation of the Met receptor (Shen et al., 2000), leading to bacterial internalization into host cells (Shen et al., 2000; Ireton, 2007; Disson et al., 2008). The 213-amino acid leucine-rich repeat portion of internalin B is sufficient for entry into mammalian cells (Braun et al., 1999). The recent cocrystallization of internalin B with the ectodomain of the Met receptor has shown that internalin B complexes with the first Ig domain of the receptor (Niemann et al., 2007; Niemann et al., 2008). This interaction keeps Met in an active configuration while maintaining the flexibility in the Met semaphorin domain, where HGF binds with low affinity (Stamos et al., 2004). The interaction interface includes the concave part of the leucine-rich domain of internalin B and a loop that protrudes from the first Ig-like domain of the Met receptor (Niemann et al., 2008). Notably, several key aromatic amino acids within the concave face of internalin B are required for Met binding and internalization of the bacteria (Machner et al., 2003). These results have been confirmed in the aforementioned cocrystallization study (Niemann et al., 2007). Mutation of each of these residues () abolishes binding to the Met receptor (Machner et al., 2003). Very importantly, a specific sequence of internalin B, encoding Y170 (required for Met binding) and surrounding residues, is highly analogous to a sequence of mammalian decorin (Fig. S5 B). This highly conserved motif suggests that both proteins have evolved to fulfill a common function, i.e., interacting with the Met receptor, albeit with divergent outcomes.
###end p 40
###begin p 41
###xml 87 106 87 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">Stamos et al., 2004</xref>
###xml 154 175 154 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Basilico et al., 2008</xref>
###xml 327 344 327 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">Shen et al., 2000</xref>
###xml 405 407 405 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 659 661 647 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
In contrast to internalin B, HGF binds with low affinity to the Met semaphorin domain (Stamos et al., 2004) and with high affinity to the terminal Ig3-4 (Basilico et al., 2008). This is in agreement with early biochemical experiments demonstrating that internalin B and HGF do not substantially compete for receptor occupancy (Shen et al., 2000). We discovered that decorin is readily displaced by HGF (IC50 = approximately2.3 nM) from binding to the immobilized Met ectodomain fused to the dimerizing Fc fragment. In contrast, internalin B was much less efficient in displacing decorin binding to Met-Fc because it required >50-fold higher concentrations (IC50 = approximately120 nM). These findings suggest that decorin binds to a similar location of the Met ectodomain where HGF binds with additional secondary sites overlapping with internalin B binding.
###end p 41
###begin p 42
###xml 720 738 711 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Monga et al., 2002</xref>
###xml 740 759 731 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">M&#252;ller et al., 2002</xref>
###xml 761 780 752 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Herynk et al., 2003</xref>
###xml 782 801 773 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Ishibe et al., 2006</xref>
###xml 803 822 794 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Rasola et al., 2007</xref>
###xml 1004 1023 989 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Rasola et al., 2007</xref>
###xml 1120 1133 1102 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Clevers, 2006</xref>
###xml 1922 1937 1880 1895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bi et al., 2008</xref>
###xml 2159 2178 2114 2133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Iozzo et al., 1999a</xref>
###xml 1723 1727 <span type="species:ncbi:10090">mice</span>
###xml 1776 1780 <span type="species:ncbi:10090">mice</span>
###xml 2057 2061 <span type="species:ncbi:10090">mice</span>
In spite of the fact that decorin mode of binding to the Met ectodomain is apparently similar to that of HGF, decorin evokes a profound antagonistic effect on the receptor signaling by inducing both physical and functional receptor down-regulation and by triggering apoptosis via induction of caspase-3/7 activity. Moreover, decorin causes Met-mediated down-regulation of beta-catenin levels and transcriptional activity. It is well established that the Met receptor not only physically interacts with beta-catenin on the cell surface but upon HGF binding, also phosphorylates beta-catenin and triggers its translocation into the nucleus and consequent transcription of genes vital for cell proliferation and migration (Monga et al., 2002; Muller et al., 2002; Herynk et al., 2003; Ishibe et al., 2006; Rasola et al., 2007). Importantly, the Met receptor and beta-catenin are engaged in a positive feedback loop that sustains tumor growth and invasion, where beta-catenin drives Met receptor expression (Rasola et al., 2007). beta-Catenin is a key player in Wnt signaling and plays a central role in cancer development (Clevers, 2006). For instance, beta-catenin regulates both differentiation and proliferation of intestinal epithelial cells by enhancing the expression of genes, such as cyclin D1 and D4, associated with tumor progression. The ability of exogenous decorin to suppress beta-catenin levels and transcriptional activity, coupled with the decorin-evoked translocation of beta-catenin from the perinuclear to plasmalemmal compartments, suggests that decorin signaling affects the beta-catenin pathway. Our data show that this effect is mediated through the Met pathway. A recent study using decorin-deficient mice has shown that approximately30% of these mutant mice develop intestinal tumors, a process that is accelerated and amplified when the decorin-deficient animals are subjected to a high risk diet (Bi et al., 2008). Notably, the endogenous beta-catenin levels were markedly increased in the intestinal epithelium of the decorin-null mice, suggesting that lack of decorin is permissive for tumorigenesis, as we hypothesized previously (Iozzo et al., 1999a), thereby providing in vivo evidence that beta-catenin might be regulated by extracellular signaling events evoked by decorin.
###end p 42
###begin p 43
###xml 381 399 373 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">Schlessinger, 2000</xref>
###xml 583 599 575 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">Zhu et al., 2005</xref>
###xml 1239 1255 1231 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Gao et al., 2009</xref>
###xml 1514 1536 1506 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">Sigismund et al., 2008</xref>
How does decorin induce protracted Met degradation? In the case of the EGFR, EGF but not TGF-alpha induces efficient receptor internalization and degradation. EGF remains closely linked to its receptor during clathrin-dependent endocytosis, whereas TGF-alpha rapidly dissociates from the receptor in the acidic microenvironment of early endosomes, resulting in receptor recycling (Schlessinger, 2000). Decorin causes a caveolar-mediated endocytosis of the EGFR, and even after 30 min, decorin and EGFR colocalize within late endocytic compartments and subsequently within lysosomes (Zhu et al., 2005). This mechanism might explain the lower levels of EGFR after decorin treatment due in part to a reduced receptor recycling to the surface. A similar scenario could occur with the Met receptor, although we have not formally shown that Met internalization and degradation occur via a caveolar-mediated endocytosis. This idea is supported by a recent study, which has shown that both internalin B and the leucine-rich repeats of internalin B, the region that shares analogy with decorin, are properly internalized and remain associated with Met during transit through early and late endosomes when provided as soluble ligands to HeLa cells (Gao et al., 2009). Thus, one possibility is that HGF/internalin B, as agonistic ligands for Met, are internalized via a clathrin-mediated pathway and in analogy with EGF/EGFR, clathrin-mediated internalization has been shown to be essential for sustained receptor signaling (Sigismund et al., 2008). In contrast, antagonistic ligands such as decorin could induce internalization via a caveolar-mediated pathway, leading to attenuated signaling and intracellular proteolysis of the receptor.
###end p 43
###begin p 44
###xml 453 473 453 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib60">Stommel et al., 2007</xref>
###xml 568 589 568 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Engelman et al., 2007</xref>
###xml 862 891 862 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Knudsen and Vande Woude, 2008</xref>
The ability of decorin to differentially phosphorylate Met receptor Tyr residues is fascinating. More investigation into this novel decorin mechanism of action will be needed in the future, and most likely, more information regarding the peculiar Met conformation induced by decorin binding will shed light onto the phosphorylation events described in this study. Notably, coactivation of RTKs affects the response of tumor cells to targeted therapies (Stommel et al., 2007), and amplification of the Met-encoding gene promotes drug resistance in ErbB-driven cancers (Engelman et al., 2007). Although in the past main efforts were aimed at developing highly specific inhibitors acting on single RTKs, more recently there has been a general consensus that molecules interfering simultaneously with multiple RTKs might be more effective than single target agents (Knudsen and Vande Woude, 2008). In this perspective, the activity of decorin, and perhaps of other molecules harboring leucine-rich repeats, might represent a novel therapeutic modality against metastatic cancer.
###end p 44
###begin title 45
Materials and methods
###end title 45
###begin title 46
Cell culture and materials
###end title 46
###begin p 47
###xml 488 492 482 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1173</sup>
###xml 501 507 495 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1234/5</sup>
###xml 516 520 510 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1003</sup>
###xml 529 533 523 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1349</sup>
###xml 1474 1490 1468 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">Zhu et al., 2005</xref>
###xml 328 333 <span type="species:ncbi:10090">mouse</span>
###xml 465 471 <span type="species:ncbi:9986">rabbit</span>
###xml 763 768 <span type="species:ncbi:9606">human</span>
###xml 1021 1027 <span type="species:ncbi:9793">donkey</span>
###xml 1033 1039 <span type="species:ncbi:9986">rabbit</span>
###xml 1044 1049 <span type="species:ncbi:9940">sheep</span>
###xml 1055 1060 <span type="species:ncbi:10090">mouse</span>
###xml 1349 1352 <span type="species:ncbi:10116">Rat</span>
###xml 1396 1401 <span type="species:ncbi:9606">Human</span>
HeLa cells were obtained from American Type Culture Collection and maintained in DME (Mediatech) supplemented with 10% FBS (PAA Laboratories, Inc). Dulbecco's phosphate buffer saline was purchased from Mediatech. Cell culture supplies were purchased from Thermo Fisher Scientific. The following antibodies were used: monoclonal mouse anti-Grb2, anti-beta-catenin, antiphosphotyrosine HRP conjugated (BD), anti-beta-actin (Sigma-Aldrich), anti-PARP (BD), monoclonal rabbit against EGFR-Tyr1173, Met-Tyr1234/5, Met-Tyr1003, Met-Tyr1349 (Cell Signaling Technology), polyclonal against Met C terminus (Santa Cruz Biotechnology, Inc.), Met N terminus (H9786 [Sigma-Aldrich] and AF276 [R&D Systems]), and HGF (Abcam). Lactacystin was purchased from Sigma-Aldrich. Anti-human decorin antibody (LC-001b) was provided by LifeCell Corporation. EGFR-blocking antibody mAb425 was provided by U. Rodeck (Thomas Jefferson University, Philadelphia, PA). The EGFR tyrosine kinase inhibitor, AG1478, was obtained from EMD. HRP-conjugated donkey anti-rabbit and sheep anti-mouse were purchased from Jackson ImmunoResearch Laboratories. Protein G- and A-Sepharose beads were obtained from GE Healthcare. S-SMPB and SuperSignal West Pico chemiluminescence substrate were purchased from Thermo Fisher Scientific. HGF, TIMP-2, and TIMP-3 were purchased from R&D Systems. Rat tail collagen type I was obtained from BD. Human recombinant decorin was expressed and purified as described previously (Zhu et al., 2005). Decorin harbors one glycosaminoglycan side chain and is fully glycosylated. Decorin protein core was obtained by expressing a mutant at the glycosaminoglycan chain attachment site. Decorin protein core is expressed in a mammalian cell system and is fully glycosylated.
###end p 47
###begin title 48
Phospho-RTK arrays, time course experiments, and blocking experiments
###end title 48
###begin p 49
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 523 524 523 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 526 527 526 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Arrays were purchased from R&D Systems. Array membranes were incubated with cell lysates and processed as recommended by the manufacturer's protocol using a Phospho-Tyr-specific antibody. Approximately 8 x 106 HeLa cells were either serum starved or maintained in full serum overnight and treated with 100 nM decorin for 15 min or left untreated. After decorin incubation, cells were washed with ice-cold PBS and lysed with a buffer containing 1% NP-40, 20 mM Tris-HCl, pH 8.0, 137 mM NaCl, 10% glycerol, 2 mM EDTA, 1 mM Na3VO4, 10 microg/ml aprotinin, and 10 microg/ml leupeptin for 30 min. Protein assay (Bio-Rad Laboratories) was performed before incubating the lysates with the RTK membranes. HeLa cells were serum starved overnight before treatment with 100 nM decorin for 5, 10, 15, 30, and 60 min. Cells were washed with ice-cold PBS and lysed in RIPA buffer. 10 microg/ml EGFR-blocking antibody mAb425 or 1 microM AG1478 were incubated with or without decorin. HGF was used at 1.5 nM. Lysates were resolved on an 8% SDS-PAGE. Cells were preincubated with mAb425 or AG1478 for 1 h before decorin treatment. Efficiency of mAb425 and AG1478 was measured by testing their ability to block EGFR phosphorylation evoked by EGF (16 nM for 5 min).
###end p 49
###begin title 50
Cross-linking and immunoprecipitation
###end title 50
###begin p 51
###xml 166 182 160 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">Zhu et al., 2005</xref>
###xml 715 716 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Cells were treated with or without 220 nM decorin protein core for 15 min and incubated with 0.5 mM of the noncleavable cross-linker S-SMPB for 20 min at 37degreesC (Zhu et al., 2005). At the end, reactions were quenched with a 90-mM glycine solution. Cells were washed with ice-cold PBS and lysed with an NP-40-containing buffer (as described in Phospho-RTK arrays, time courseem leader). Cell extracts were subjected to immunoprecipitation with an anti-C terminus Met receptor antibody, separated on a 6% SDS-PAGE, and immunoblottings for Met and decorin were performed. Met was also immunoprecipitated to examine c-Cbl and Grb2 recruitment to the receptor before and after decorin treatment. Approximately 3 x 106 HeLa cells were serum starved overnight for this purpose.
###end p 51
###begin title 52
Pull-down- and solid-phase-binding assays
###end title 52
###begin p 53
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 703 708 <span type="species:ncbi:9606">human</span>
Human Met-Fc chimera (Sigma-Aldrich) was bound to protein A-Sepharose beads (GE Healthcare). 2 microg human Met/Fc chimera was added to 20 microl protein A-Sepharose beads. After an overnight incubation with rotation at 4degreesC, the beads were extensively washed with PBS and resuspended in 400 microl of serum-free medium containing Complete Mini protease inhibitor (Roche). The mixture was incubated with equimolar amounts of various ligands at 37degreesC for 3 h. The beads were collected by centrifugation, extensively washed with a buffer containing 0.1% Triton X-100, boiled in reducing sample buffer, and subjected to electrophoresis on an 8% SDS-PAGE. In these experiments, antibodies against human HGF (Abcam) and decorin (Santa Cruz Biotechnology, Inc.) were used. ELISAs were performed following a standard protocol. The substrates, either Met-Fc (100 ng/well) or neutralized fibrillar collagen type I (1 mg/ml; 50 microl/well), were allowed to adhere to the wells (BD) overnight at room temperature in the presence of carbonate buffer, pH 9.6. Plates were washed with PBS and incubated for 3 h with serial dilutions of decorin or decorin core. In the competition experiments, decorin core was kept at constant concentration (10 nM) and incubated with increasing concentrations of either internalin B or HGF. After ligand incubation, plates were extensively washed with PBS, blocked with 1% BSA solution in PBS, and incubated with primary and HRP-conjugated secondary antibodies. Signal was developed using Sigma-Fast tablets (Sigma-Aldrich) and read at 450-nm OD. To correct for antibody affinity, the values obtained were converted to bound ligand (nanomolars) by performing separate ELISA experiments using increasing amounts of each ligand and extrapolating from the generated standard curves.
###end p 53
###begin title 54
Ectodomain shedding and slot blot
###end title 54
###begin p 55
HeLa cells were serum starved overnight and treated with 100 nM decorin for 5-30 min. Conditioned media from decorin-treated cells and controls were collected, slot blotted, and probed for the N-terminal domain of the Met receptor. For the inhibition of shedding experiments, 1 microM TIMP-2 and TIMP-3 were incubated for 30 min before decorin treatment (100 nM for 30 min). Both lysates and media were collected and analyzed by Western analysis and slot blot, respectively. Lysates were probed with a Met antibody recognizing the intracellular domain of the receptor, whereas media with an antibody raised against the Met extracellular domain.
###end p 55
###begin title 56
Met internalization experiments
###end title 56
###begin p 57
###xml 1099 1100 1093 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1304 1305 1292 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 329 335 <span type="species:ncbi:9793">donkey</span>
###xml 341 345 <span type="species:ncbi:9925">goat</span>
Cells for immunofluorescence were grown on chamber glass slides, treated with decorin, washed with PBS, fixed in ice-cold methanol for 5 min, and stained according to standard procedures. To detect Met, the AF276 antibody (R&D Systems) raised against the N terminus domain of the receptor was used followed by an FITC-conjugated donkey anti-goat antibody (Santa Cruz Biotechnology, Inc.). Images were acquired on a laser-scanning confocal microscopy system (LSM 510 META; Carl Zeiss Inc.) driven by imaging software (LSM 510; Carl Zeiss, Inc.). 63x magnification was used with a 1.25 objective lens aperture. Confocal image processing, including z stacks, was performed with ImageJ (National Institutes of Health). Contrast enhancement was applied uniformly to all panels. A microscope (BX51; Olympus) driven by SPOT Advanced imaging software (version 4.0.9; Diagnostic Instruments, Inc.) was used to acquire fluorescence images with 40x magnification and 0.75 aperture. FITC signal was acquired at 25degreesC. Vectashield mounting medium was purchased from Vector Laboratories. Approximately 8 x 106 HeLa cells were serum starved for 1 h before decorin treatment (100 nM for 5 and 30 min). Cells were trypsinized with 0.2% trypsin (Cellgro) for 5 min at 37degreesC and pelleted by centrifugation at 300 g for 5 min. The pellet was dissolved in RIPA buffer, and samples were run on SDS-PAGE.
###end p 57
###begin title 58
beta-Catenin experiments and migration assays
###end title 58
###begin p 59
###xml 865 883 853 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla reniformis</italic>
###xml 982 995 970 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R. reniformis</italic>
###xml 483 487 <span type="species:ncbi:9925">goat</span>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
###xml 865 883 <span type="species:ncbi:6136">Renilla reniformis</span>
###xml 982 995 <span type="species:ncbi:6136">R. reniformis</span>
For the beta-catenin experiments, subconfluent HeLa cells in DME full serum were used. Cells were treated with 100 nM decorin from 30 min to 24 h. For the GSK3-beta inhibition experiments, cells were incubated with 30 mM LiCl for 1 h before decorin treatment. Cells for immunofluorescence were grown on chamber slides, treated with decorin, fixed in ice-cold methanol for 5 min, and stained according to standard procedures. To detect the beta-catenin signal, a rhodamine-conjugated goat anti-mouse antibody was used (Santa Cruz Biotechnology, Inc.). To study the effect of decorin on beta-catenin transcriptional activity, we used the TopFlash luciferase reporter vector (Addgene). TopFlash vector was provided by M. Pacifici (Thomas Jefferson University, Philadelphia, PA). Subconfluent HeLa cells in 12-well plates were transfected overnight with TopFlash and a Renilla reniformis luciferase reporter vector (phRL-TK; Promega) as transfection control in the ratio 10:1 (TopFlash:R. reniformis) using Lipofectamine2000 (Invitrogen). The next day, media were changed and cells were treated with or without 30 mM LiCl for 1 h before decorin (100 nM) stimulation for 6 h. Cells were lysed, and the luciferase activity was measured using a dual luciferase assay kit (Promega). The FopFlash mutant was used vis a vis the TopFlash vector as negative control to evaluate the background signal. No luciferase activity was observed with the FopFlash vector.
###end p 59
###begin p 60
For migration assays, HeLa cells were grown to confluency in 12-well plates and scratched with a pipette tip. Cells were incubated for 24 h with or without 100 nM decorin, 1 microM AG1478, and 2 microg/ml Met-blocking antibody H9786 in full serum. Blocking agents were incubated for 1 h before decorin treatment. An inverted phase-contrast microscope (IM; Olympus) with 10x magnification and 0.25 aperture was used. Pictures were taken over time with a digital microscope camera (DP12; Olympus).
###end p 60
###begin title 61
Quantification and statistical analysis
###end title 61
###begin p 62
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Immunoblots were quantified by scanning densitometry using Scion Image software (National Institutes of Health). Graphs were generated using SigmaStat (version 3.10; Systat Software, Inc.). Significance of the differences was evaluated by Student's t test. Fluorescence intensity was quantified by measuring pixels with ImageJ software. In the scratch assay, wound closure was measured with ImageJ. The mean of three linear distances between the two edges of the wound was measured. Three wounds per condition were analyzed. Three independent experiments were run. All data presented were collected from three independent experiments run in triplicates or quadruplicates.
###end p 62
###begin title 63
Online supplemental material
###end title 63
###begin p 64
Fig. S1 shows a representative HGF/Met-Fc solid-phase binding curve and negative controls for the binding experiments, decorin/IgG, and LG3/Met-Fc. Fig. S2 shows decorin-induced Met ectodomain shedding and Met internalization after decorin binding. Fig. S3 shows induction of apoptosis downstream of decorin-evoked Met phosphorylation and down-regulation of Met by decorin treatment in full serum followed by recovery of Met expression upon decorin withdrawal. Fig. S4 shows a motility assay. Fig. S5 presents the 3D structure of internalin B leucine-rich repeats and a key portion of the sequence alignment with decorin. Online supplemental material is available at .
###end p 64
###begin title 65
Supplementary Material
###end title 65
###begin title 66
[Supplemental Material Index]
###end title 66
###begin p 67
We thank U. Rodeck for providing the mAb425 and M. Pacifici for the TopFlash vector. We also thank M. Sobkowiak and A. Kelsey for valuable help, George Purkins with 3D modeling, and A. McQuillan for help with the graphics.
###end p 67
###begin p 68
This work was supported in part by the National Institutes of Health grants (RO1 CA39481, RO1 CA47282, and RO1 CA120975 to R.V. Iozzo) and a Canadian Institutes of Health Research grant (MT-15497 to K. Ireton).
###end p 68
###begin article-title 69
beta-catenin is a target for the ubiquitin-proteasome pathway.
###end article-title 69
###begin article-title 70
c-Met ectodomain shedding rate correlates with malignant potential.
###end article-title 70
###begin article-title 71
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met.
###end article-title 71
###begin article-title 72
The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants.
###end article-title 72
###begin article-title 73
Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation.
###end article-title 73
###begin article-title 74
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model.
###end article-title 74
###begin article-title 75
MET, metastasis, motility and more.
###end article-title 75
###begin article-title 76
Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy.
###end article-title 76
###begin article-title 77
###xml 53 75 53 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 53 75 <span type="species:ncbi:1639">Listeria monocytogenes</span>
The 213-amino-acid leucine-rich repeat region of the Listeria monocytogenes lnlB protein is sufficient for entry into mammalian cells, stimulation of Pl 3-kinase and membrane ruffling.
###end article-title 77
###begin article-title 78
Wnt/beta-catenin signaling in development and disease.
###end article-title 78
###begin article-title 79
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo.
###end article-title 79
###begin article-title 80
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors.
###end article-title 80
###begin article-title 81
Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis.
###end article-title 81
###begin article-title 82
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MET</italic>
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
###end article-title 82
###begin article-title 83
###xml 98 106 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lysteria</italic>
Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Lysteria invasion protein internalin B.
###end article-title 83
###begin article-title 84
The Met tyrosine kinase receptor in development and cancer.
###end article-title 84
###begin article-title 85
Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs.
###end article-title 85
###begin article-title 86
An anti-metastatic role for decorin in breast cancer.
###end article-title 86
###begin article-title 87
Decorin suppresses tumor cell-mediated angiogenesis.
###end article-title 87
###begin article-title 88
Endosomal dynamics of Met determine signaling output.
###end article-title 88
###begin article-title 89
Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phopshorylated beta-catenin.
###end article-title 89
###begin article-title 90
Matrix proteoglycans: from molecular design to cellular function.
###end article-title 90
###begin article-title 91
Basement membrane proteoglycans: from cellar to ceiling.
###end article-title 91
###begin article-title 92
Cooperative action of germline mutations in decorin and p53 accelerates lymphoma tumorigenesis.
###end article-title 92
###begin article-title 93
Decorin is a biological ligand for the epidermal growth factor receptor.
###end article-title 93
###begin article-title 94
###xml 23 45 23 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 23 45 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Entry of the bacterial Listeria monocytogenes into mammalian cells.
###end article-title 94
###begin article-title 95
Cell confluence regulates hepatocyte growth factor-stimulated cell morphogenesis in a beta-catenin-dependent manner.
###end article-title 95
###begin article-title 96
Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells.
###end article-title 96
###begin article-title 97
A molecular mechanism for the effect of lithium on development.
###end article-title 97
###begin article-title 98
Showering c-MET-dependent cancers with drugs.
###end article-title 98
###begin article-title 99
Tyrosine kinase inhibition: an approach to drug development.
###end article-title 99
###begin article-title 100
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
The Listeria protein internalin B mimics hepatocyte growth factor-induced receptor trafficking.
###end article-title 100
###begin article-title 101
Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase.
###end article-title 101
###begin article-title 102
ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
###end article-title 102
###begin article-title 103
Role of decorin in the antimyeloma effects of osteoblasts.
###end article-title 103
###begin article-title 104
###xml 84 106 84 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 84 106 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Aromatic amino acids at the surface of InIB are essential for host cell invasion by Listeria monocytogenes.
###end article-title 104
###begin article-title 105
Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after MET-beta-catenin dissociation in hepatocytes.
###end article-title 105
###begin article-title 106
Regulation of epithelial cell migration and tumor formation by beta-catenin signaling.
###end article-title 106
###begin article-title 107
Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase.
###end article-title 107
###begin article-title 108
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Structure of the human receptor tyrosine kinase Met in complex with the Listeria invasion protein lnlB.
###end article-title 108
###begin article-title 109
###xml 100 122 100 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 100 122 <span type="species:ncbi:1639">Listeria monocytogenes</span>
X-ray and neutron small-angle scattering analysis of the complex formed by the Met receptor and the Listeria monocytogenes invasion protein InIB.
###end article-title 109
###begin article-title 110
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neu</italic>
###xml 172 180 172 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 185 192 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Neutralizing antibodies against epidermal growth factor and Erb-2/neu receptor tyrosine kinases down-regulated vascular endothelial growth factor production by tumor cells in vitro and in vivo. Angiogenic implications for signal transduction therapy of solid tumors.
###end article-title 110
###begin article-title 111
The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met.
###end article-title 111
###begin article-title 112
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity.
###end article-title 112
###begin article-title 113
Cell signaling events: a view from the matrix.
###end article-title 113
###begin article-title 114
A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth.
###end article-title 114
###begin article-title 115
Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin.
###end article-title 115
###begin article-title 116
Decorin prevents metastatic spreading of breast cancer.
###end article-title 116
###begin article-title 117
Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.
###end article-title 117
###begin article-title 118
Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects.
###end article-title 118
###begin article-title 119
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">De novo</italic>
###xml 70 75 <span type="species:ncbi:9606">human</span>
De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells.
###end article-title 119
###begin article-title 120
An anti-oncogenic role for decorin: downregulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells.
###end article-title 120
###begin article-title 121
Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction.
###end article-title 121
###begin article-title 122
Cell signaling by receptor tyrosine kinases.
###end article-title 122
###begin article-title 123
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation.
###end article-title 123
###begin article-title 124
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria</italic>
lnlB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase.
###end article-title 124
###begin article-title 125
###xml 38 44 <span type="species:ncbi:10090">murine</span>
Decorin suppresses lung metastases of murine osteosarcoma.
###end article-title 125
###begin article-title 126
Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation.
###end article-title 126
###begin article-title 127
Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor.
###end article-title 127
###begin article-title 128
Coactivation of receptor tyrosine kinases affects the response of tumor cells to target therapies.
###end article-title 128
###begin article-title 129
In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer.
###end article-title 129
###begin article-title 130
Scatter-factor and semaphorin receptors: cell signalling for invasive growth.
###end article-title 130
###begin article-title 131
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.
###end article-title 131
###begin article-title 132
Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells.
###end article-title 132
###begin article-title 133
Decorin evokes protracted internalization and degradation of the EGF receptor via caveolar endocytosis.
###end article-title 133
###begin p 134
Abbreviations used in this paper: EGFR, EGF receptor; HGF, hepatocyte growth factor; IC, inhibitory concentration; PARP, poly ADP-ribose polymerase; RTK, receptor tyrosine kinase.
###end p 134

